日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Clinical characteristics and management of paroxysmal nocturnal haemoglobinuria in Latin America: a narrative review

拉丁美洲阵发性睡眠性血红蛋白尿的临床特征和治疗：叙述性综述

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-024-05968-6
Goldschmidt, Valentina; Apodaca, Elia Ixel; Gálvez, Kenny Mauricio; Wannesson, Bruno; Scheinberg, Phillip
发表日期：2025
文献求助 收藏

Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma

在65岁及以上复发/难治性大B细胞淋巴瘤患者中，Axicabtagene Ciloleucel与标准治疗相比的安全性和有效性

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-3136
Westin, Jason R; Locke, Frederick L; Dickinson, Michael; Ghobadi, Armin; Elsawy, Mahmoud; van Meerten, Tom; Miklos, David B; Ulrickson, Matthew L; Perales, Miguel-Angel; Farooq, Umar; Wannesson, Luciano; Leslie, Lori; Kersten, Marie José; Jacobson, Caron A; Pagel, John M; Wulf, Gerald; Johnston, Patrick; Rapoport, Aaron P; Du, Linqiu; Vardhanabhuti, Saran; Filosto, Simone; Shah, Jina; Snider, Julia T; Cheng, Paul; To, Christina; Oluwole, Olalekan O; Sureda, Anna
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2023
文献求助 收藏

Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma

ZUMA-7 是一项评估 axicabtagene ciloleucel 治疗二线大 B 细胞淋巴瘤的 3 期研究，其中患者报告的结局如下

期刊:Blood
影响因子:23.1
doi:10.1182/blood.2022015478
Elsawy, Mahmoud; Chavez, Julio C; Avivi, Irit; Larouche, Jean-François; Wannesson, Luciano; Cwynarski, Kate; Osman, Keren; Davison, Kelly; Rudzki, Jakob D; Dahiya, Saurabh; Dorritie, Kathleen; Jaglowski, Samantha; Radford, John; Morschhauser, Franck; Cunningham, David; Martin Garcia-Sancho, Alejandro; Tzachanis, Dimitrios; Ulrickson, Matthew L; Karmali, Reem; Kekre, Natasha; Thieblemont, Catherine; Enblad, Gunilla; Dreger, Peter; Malladi, Ram; Joshi, Namita; Wang, Wei-Jhih; Solem, Caitlyn T; Snider, Julia Thornton; Cheng, Paul; To, Christina; Kersten, Marie José
细胞生物学
淋巴瘤
T细胞
发表日期：2022
文献求助 收藏

Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers

K-Ras突变型非小细胞肺癌的分子生物学和治疗前景

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers14174103
Cekani, Elona; Epistolio, Samantha; Dazio, Giulia; Cefalì, Marco; Wannesson, Luciano; Frattini, Milo; Froesch, Patrizia
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program

卡马替尼治疗MET 14号外显子突变型非小细胞肺癌的真实世界经验（RECAP）：一项来自早期准入项目的回顾性分析

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359221103206
Illini, Oliver; Fabikan, Hannah; Swalduz, Aurélie; Vikström, Anders; Krenbek, Dagmar; Schumacher, Michael; Dudnik, Elizabeth; Studnicka, Michael; Öhman, Ronny; Wurm, Robert; Wannesson, Luciano; Peled, Nir; Kian, Waleed; Bar, Jair; Daher, Sameh; Addeo, Alfredo; Rotem, Ofer; Pall, Georg; Zer, Alona; Saad, Akram; Cufer, Tanja; Sorotsky, Hadas Gantz; Hashemi, Sayed M S; Mohorcic, Katja; Stoff, Ronen; Rovitsky, Yulia; Keren-Rosenberg, Shoshana; Winder, Thomas; Weinlinger, Christoph; Valipour, Arschang; Hochmair, Maximilian J
肺癌
肿瘤
肿瘤免疫
细胞生物学
MET
发表日期：2022
文献求助 收藏

Lurbinectedin improves macular edema in a case of central retinal vein occlusion

鲁比奈德定可改善中心性视网膜静脉阻塞引起的黄斑水肿

期刊:American Journal of Ophthalmology Case Reports
影响因子:
doi:10.1016/j.ajoc.2022.101743
Simona, Filippo; Menna, Feliciana; Wannesson, Luciano; Meduri, Alessandro; De Salvo, Gabriella; Querques, Giuseppe
发表日期：2022
文献求助 收藏

SAKK 19/17: safety analysis of first-line durvalumab in patients with PD-L1 positive, advanced nonsmall cell lung cancer and a performance status of 2

SAKK 19/17：对PD-L1阳性、晚期非小细胞肺癌且体能状态评分为2的患者进行一线度伐利尤单抗治疗的安全性分析

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-020-02757-8
Mark, Michael; Froesch, Patrizia; Eboulet, Eric Innocents; Addeo, Alfredo; Pless, Miklos; Rothschild, Sacha I; Janthur, Wolf-Dieter; Burmeister, Henning; Friedlaender, Alex; Schneider, Martina; Metaxas, Yannis; Joerger, Markus; Wannesson, Luciano; Schwitter, Michael; Baudoux, Nathalie; Weindler, Susanne; Biaggi-Rudolf, Christine; Früh, Martin
肺癌
肿瘤
肿瘤免疫
PD-L1
细胞生物学
发表日期：2021
文献求助 收藏

Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohort

瑞士队列研究中，免疫检查点抑制剂治疗复发性小细胞肺癌的疗效

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-020-02565-0
Schmid, Sabine; Mauti, Laetitia A; Friedlaender, Alex; Blum, Veronika; Rothschild, Sacha I; Bouchaab, Hasna; Frösch, Patrizia; Britschgi, Christian; König, David; Wannesson, Luciano; Janthur, Wolf-Dieter; Schär, Sämi; Demmer, Izadora; Addeo, Alfredo; Jochum, Wolfram; Früh, Martin
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2020
文献求助 收藏

Functional and clinical significance of ROR1 in lung adenocarcinoma

ROR1在肺腺癌中的功能和临床意义

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-020-07587-6
Schiavone, Giovanna; Epistolio, Samantha; Martin, Vittoria; Molinari, Francesca; Barizzi, Jessica; Mazzucchelli, Luca; Frattini, Milo; Wannesson, Luciano
肿瘤
肿瘤免疫
ROR1
发表日期：2020
文献求助 收藏

Correction to: Functional and clinical significance of ROR1 in lung adenocarcinoma

更正：ROR1在肺腺癌中的功能和临床意义

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-020-07704-5
Schiavone, Giovanna; Epistolio, Samantha; Martin, Vittoria; Molinari, Francesca; Barizzi, Jessica; Mazzucchelli, Luca; Frattini, Milo; Wannesson, Luciano
肿瘤
肿瘤免疫
ROR1
发表日期：2020
文献求助 收藏